IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 46 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,305,000 | -13.4% | 950,000 | 0.0% | 0.76% | -15.3% |
| Q2 2023 | $56,962,000 | +21.3% | 950,000 | 0.0% | 0.90% | +64.5% |
| Q1 2023 | $46,968,000 | -13.4% | 950,000 | 0.0% | 0.55% | -24.0% |
| Q4 2022 | $54,216,500 | +21.6% | 950,000 | 0.0% | 0.72% | +36.8% |
| Q3 2022 | $44,593,000 | +25.8% | 950,000 | 0.0% | 0.52% | +13.4% |
| Q2 2022 | $35,445,000 | +24.8% | 950,000 | 0.0% | 0.46% | +78.1% |
| Q1 2022 | $28,405,000 | -12.7% | 950,000 | 0.0% | 0.26% | +3.6% |
| Q4 2021 | $32,528,000 | -7.6% | 950,000 | 0.0% | 0.25% | +21.8% |
| Q3 2021 | $35,217,000 | -5.1% | 950,000 | 0.0% | 0.21% | -21.4% |
| Q2 2021 | $37,098,000 | -8.3% | 950,000 | 0.0% | 0.26% | -44.7% |
| Q1 2021 | $40,442,000 | – | 950,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |